Interferon alfa-2a overdosage

Interferon alfa-2a
PEGASYS^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overdosage

There are no reports of overdosage, but repeated large doses of interferon can be associated with profound lethargy, fatigue, prostration, and coma. Such patients should be hospitalized for observation and appropriate supportive treatment given.^[1]

References

↑ “http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf” (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.

[1] “http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103964s5204lbl.pdf” (PDF). External link in |title= (help)

[1]